Oxford University to launch trial alternating coronavirus vaccines from AstraZeneca and Pfizer-BioNTech
Posted
ThuThursday 4
FebFebruary 2021 at 11:14am
If proven successful, and approved by regulators, alternating vaccines could allow greater flexibility in pressured vaccine delivery schedules.
(
Print text only
Cancel
Oxford University says it will launch a trial alternating doses of COVID-19 vaccines created by different manufacturers.
Key points:
The trial aims to determine whether different COVID-19 doses can be used interchangeably
If successful, it could lead to a more flexible vaccine rollout, says the UK s chief health officer
Britain has been administering vaccines at an interval of 12 weeks to give more people a first dose, unlike other countries
In the week when the UK death toll from Covid-19 passed the 100,000 mark, Labour’s attack on Boris Johnson’s handling of the response to the pandemic misfired.
At Prime Minister’s Questions, Sir Keir demanded major changes to the vaccine priority list drawn up by scientific experts on the Joint Committee on Vaccination and Immunisation.
He called for all teachers to be given jabs during next month’s half-term break to rush forward the reopening of schools. Downing Street insisted the move would delay vaccinations for millions of people aged over 60 and others with underlying health conditions.
BY the afternoon, the policy proposal was unravelling, with Deputy Chief Medical Officer Jonathan Van-Tam pointing out that the data suggested there was no “markedly increased rate of infection or mortality” among teachers.
Vaccinated people may still spread Covid: UK expert prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.